SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001607062-18-000491
Filing Date
2018-12-27
Accepted
2018-12-27 12:55:00
Documents
63
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K rgbp093018form10k.htm 10-K 1964324
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 7470
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 7445
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4613
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4463
6 EXHIBIT 10.4 ex10_4.htm EX-10.4 26735
  Complete submission text file 0001607062-18-000491.txt   5925235

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE rgbp-20180930.xml EX-101.INS 880634
8 XBRL SCHEMA FILE rgbp-20180930.xsd EX-101.SCH 63991
9 XBRL CALCULATION FILE rgbp-20180930_cal.xml EX-101.CAL 46725
10 XBRL DEFINITION FILE rgbp-20180930_def.xml EX-101.DEF 214059
11 XBRL LABEL FILE rgbp-20180930_lab.xml EX-101.LAB 304038
12 XBRL PRESENTATION FILE rgbp-20180930_pre.xml EX-101.PRE 282844
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 333-191725 | Film No.: 181254280
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences